Correction: Cilostazol and isosorbide mononitrate for the prevention of progression of : baseline data and statistical analysis plan for the Lacunar Intervention Trial-2 (LACI-2) (ISRCTN14911850).

IF 4.4 1区医学 Q1 CLINICAL NEUROLOGY

Stroke and Vascular Neurology Pub Date : 2023-04-01 DOI:10.1136/svn-2022-001816corr1

引用次数: 1

查看原文本刊更多论文

校正:西洛他唑和单硝酸异山梨酯预防:腔隙干预试验-2 (LACI-2) (ISRCTN14911850)的基线数据和统计分析计划。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Stroke and Vascular Neurology Medicine-Cardiology and Cardiovascular Medicine

CiteScore

11.20

自引率

1.70%

发文量

审稿时长

15 weeks

期刊介绍： Stroke and Vascular Neurology (SVN) is the official journal of the Chinese Stroke Association. Supported by a team of renowned Editors, and fully Open Access, the journal encourages debate on controversial techniques, issues on health policy and social medicine.